CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...